Results 211 to 220 of about 74,283 (261)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Obstetrics & Gynaecology, 2006
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
Israel Zighelboim +2 more
+5 more sources
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
Israel Zighelboim +2 more
+5 more sources
Vaccine, 2008
The availability of two prophylactic HPV vaccines will require thorough considerations about monitoring and surveillance of those vaccinated and the general population, respectively. Vaccinated populations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy.
Margaret, Stanley, Luisa Lina, Villa
openaire +2 more sources
The availability of two prophylactic HPV vaccines will require thorough considerations about monitoring and surveillance of those vaccinated and the general population, respectively. Vaccinated populations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy.
Margaret, Stanley, Luisa Lina, Villa
openaire +2 more sources
Frontiers in Bioscience, 2003
Human papillomaviruses (HPV), particularly HPV type 16, are the primary etiologic agent of cervical cancer. Thus, HPV-associated cervical malignancies might be prevented or treated by induction of the appropriate virus-specific immune responses in patients.
Michelle, Moniz +3 more
openaire +2 more sources
Human papillomaviruses (HPV), particularly HPV type 16, are the primary etiologic agent of cervical cancer. Thus, HPV-associated cervical malignancies might be prevented or treated by induction of the appropriate virus-specific immune responses in patients.
Michelle, Moniz +3 more
openaire +2 more sources
Expert Opinion on Biological Therapy, 2010
Cervical cancer is a major cause of morbidity and mortality worldwide and is common in relatively young women. Cervical screening programs, while successful if properly carried out, are difficult and expensive to implement, and offer secondary, not primary prevention.
openaire +2 more sources
Cervical cancer is a major cause of morbidity and mortality worldwide and is common in relatively young women. Cervical screening programs, while successful if properly carried out, are difficult and expensive to implement, and offer secondary, not primary prevention.
openaire +2 more sources
BMJ, 2011
Most deaths from cervical cancer occur in countries without the resources to screen, treat, or vaccinate against the disease.
openaire +2 more sources
Most deaths from cervical cancer occur in countries without the resources to screen, treat, or vaccinate against the disease.
openaire +2 more sources